Get started
Author

Ayal Aizer

Observed name: A.A. Aizer
ORCID: 0009-0008-9795-0067
Observed ORCIDs: 0009-0008-9795-0067, 0000-0002-8941-188X
OpenAlex ID: A5031458327
Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2024 · Grant M. Fischer, Nayan Lamba, et al. · Clinical Cancer Research · 4
Rtad-03 the Role of Radiotherapy in Resected Non-small Cell Lung Cancer Brain Metastases Treated With Cns-active Tyrosine Kinase Inhibitors
2026 · Abrar Choudhury, F Katie Keane, et al. · Neuro-Oncology Advances
Rtad-05 Local Recurrence and Radionecrosis With 3-fraction Stereotactic Radiotherapy for Postoperative Cavities and Intact Brain Metastases: a Prospective Registry Study
2026 · Pranav Samineni, Sandeep Purohit, et al. · Neuro-Oncology Advances
PDF
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data
2026 · Tulika Rudra Gupta, Mei-Yin C. Polley, et al. · Journal of Clinical Oncology
Radt-41. the Role of Radiotherapy in Resected Non-small Cell Lung Cancer Brain Metastases Treated With Cns-active Tyrosine Kinase Inhibitors
2025 · Abrar Choudhury, Florence Keane, et al. · Neuro-Oncology
PDF
Data from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Supplementary Table S6 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Supplementary Table S1 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Supplementary Table S2 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Supplementary Table S5 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Supplementary Table S4 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Supplementary Figures S1-S21 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Supplementary Table S3 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Supplementary Table S1 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Supplementary Figures S1-S21 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Supplementary Table S6 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Supplementary Table S3 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Supplementary Table S4 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Supplementary Table S5 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Supplementary Table S2 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
2025 · Grant M. Fischer, Nayan Lamba, et al.
Clinical and Genomic Characterization of Esophageal Cancer Brain Metastases
2022 · D.D. Yang, D.J. Papke, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Works count: 21
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type